)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
GoodRx
GoodRx (GDRX) investor relations material
GoodRx Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary7 May, 2026
Executive summary
Q1 2026 revenue was $194.0 million, down 4% year-over-year, with net income of $1.2 million and adjusted EBITDA of $58.3 million (30% margin); performance was impacted by retail pharmacy closures and lower prescription transactions, but Pharma Direct and subscriptions showed strong growth.
Pharma Direct revenue surged 82% year-over-year to $52.2 million, driven by manufacturer-sponsored pricing programs, GLP-1 access, and expanded market penetration.
Subscription revenue increased 16% year-over-year to $24.4 million, led by new condition-specific programs and GoodRx for Weight Loss.
Prescription transactions revenue declined 24% year-over-year to $113.7 million, attributed to fewer Monthly Active Consumers and retail pharmacy disruptions.
Launched Employer Direct platform and expanded collaborations with pharma manufacturers, including early integration with TrumpRx.gov.
Financial highlights
Q1 2026 revenue was $194 million; Adjusted EBITDA reached $58.3 million (30% margin), and net income margin was 0.6%, down from 5.4% in Q1 2025.
Pharma Direct revenue grew to $52.2 million, up 82% year-over-year; subscription revenue rose 16% to $24.4 million.
Cost of revenue increased 51% year-over-year, mainly from acquired business delivery costs and Pharma Direct fulfillment.
Share repurchases totaled 5.5 million shares for $12.6 million in Q1 2026.
Cash and cash equivalents stood at $235.7 million as of March 31, 2026, with total outstanding debt of $493.8 million.
Outlook and guidance
Full-year 2026 revenue guidance raised to $765–$785 million, with Adjusted EBITDA expected to exceed $235 million.
Pharma Direct revenue projected to grow over 50% year-over-year in 2026.
Subscription revenue expected to build as condition-specific programs scale.
Overall revenue is expected to decline 1–4% year-over-year from $796.9 million in 2025.
Continued pressure anticipated on prescription transactions revenue due to retail pharmacy changes.
Strategic rationale for lower MAC unit economics
Role of consumer direct pricing in Pharma Direct
Assess the competitive threat of TrumpRx.gov
Competitive edge in weight loss subscriptions
GoodRx share of Wegovy Pill market transactions
Pharma Direct expansion into employer channels
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from GoodRx
- Board recommends approval of all proposals at the virtual 2026 Annual Meeting.GDRX
Proxy filing29 Apr 2026 - Definitive additional proxy materials filed to inform shareholders of voting matters.GDRXProxy filing29 Apr 2026
- Sharpened strategy and robust growth in integrated savings and pharma solutions drive margin gains.GDRXMorgan Stanley 22nd Annual Global Healthcare Conference5 Apr 2026
- Pharma Direct revenue surged 41% in 2025, driving growth despite headwinds in other segments.GDRXQ4 202526 Feb 2026
- Q3 2025 saw strong manufacturer solutions growth and resilient financials amid industry headwinds.GDRXQ3 20253 Feb 2026
- Q2 revenue up 6% to $200.6M, Adjusted EBITDA margin 32.6%, with cautious full-year outlook.GDRXQ2 20242 Feb 2026
- Direct contracting, pharma partnerships, and PBM deals drive growth and competitive edge.GDRX2024 Wells Fargo Healthcare Conference22 Jan 2026
- Q3 2024 revenue up 8%, net income $4.0M, and margin expansion driven by pharma solutions.GDRXQ3 202416 Jan 2026
- Direct contracting and manufacturer solutions drive growth and margin gains amid evolving PBM dynamics.GDRXUBS Global Healthcare Conference 202414 Jan 2026
Next GoodRx earnings date
Q2 20266 Aug, 2026
GoodRx
Next GoodRx earnings date
Q2 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage